Kahira Pharmaceuticals and Chemical Industries Co. Kahira Pharmaceuticals and Chemical Industries Co SAE is an Egypt-based company engaged in the Pharmaceutical sector. The Company is primarily involved in the manufacture and trade of pharmaceutical products for human and veterinary use. The Company is characterized by its production of soft gelatin capsules, eye drops, film & sugar coated tablets, natural product and cosmetics, among other natural products. The Company owns a plant, which is specialized in production of cephalosporins. The Company is an affiliate of Holding Company for Pharmaceuticals Chemicals and Medical Appliances (Holldipharma).
Ford US Equity Research covers more than 4,000 stocks using a proprietary quantitative model that evaluates a company’s earnings strength, its relative valuation and recent price movement. Ford’s five recommendation ratings include strong buy, buy, hold, sell, strong sell. For all stocks in our coverage universe, ratings are generated each week and reflect the fundamental and price data as of the last trading day of the week.
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the week.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.